Literature DB >> 27681077

The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial.

Shahnaz Ahmadi1, Mehri Jamilian2, Maryam Tajabadi-Ebrahimi3, Parvaneh Jafari4, Zatollah Asemi5.   

Abstract

To the best of our knowledge, data on the effects of synbiotic supplementation on markers of insulin metabolism and lipid concentrations in patients with gestational diabetes mellitus (GDM) are scarce. The aim of the current study was to determine the effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in GDM patients. In total, seventy patients with GDM aged 18-40 years were assigned to two groups - the synbiotic group (n 35) and the placebo group (n 35) - in this randomised, double-blind, placebo-controlled trial. Patients in the synbiotic group received a daily capsule that contained three viable and freeze-dried strains: Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium bifidum (2×109 colony-forming units/g each) plus 800 mg inulin for 6 weeks. Fasting blood samples were collected at the beginning and week 6 to quantify related markers. After 6 weeks of intervention, compared with the placebo, synbiotic supplementation led to a significant decrease in serum insulin levels (-1·5 (sd 5·9) v. +4·8 (sd 11·5) µIU/ml, P=0·005), homoeostatic model assessment for insulin resistance (-0·4 (sd 1·3) v. +1·1 (sd 2·7), P=0·003) and homoeostatic model assessment for β cell function (-5·1 (sd 24·2) v. +18·9 (sd 45·6), P=0·008) and a significant increase in quantitative insulin sensitivity check index (+0·01 (sd 0·01) v. -0·007 (sd 0·02), P=0·02). In addition, synbiotic intake significantly decreased serum TAG (-14·8 (sd 56·5) v. +30·4 (sd 37·8) mg/dl, P<0·001) and VLDL-cholesterol concentrations (-3·0 (sd 11·3) v. +6·1 (sd 7·6) mg/dl, P<0·001) compared with the placebo. Overall, the results of this study demonstrate that taking synbiotic supplements for 6 weeks among patients with GDM had beneficial effects on markers of insulin metabolism, TAG and VLDL-cholesterol concentrations.

Entities:  

Keywords:  CFU colony-forming units; FOS fructo-oligosaccharides; FPG fasting plasma glucose; GDM gestational diabetes mellitus; HOMA-IR homoeostasis model of assessment for insulin resistance; Gestational diabetes mellitus; Insulin resistance; Lipid profiles; Synbiotic supplementation

Mesh:

Substances:

Year:  2016        PMID: 27681077     DOI: 10.1017/S0007114516003457

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  20 in total

1.  The Effects of Synbiotic Supplementation on Pregnancy Outcomes in Gestational Diabetes.

Authors:  Maryam Karamali; Nabiollah Nasiri; Naemeh Taghavi Shavazi; Mehri Jamilian; Fereshteh Bahmani; Maryam Tajabadi-Ebrahimi; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

Review 2.  Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review.

Authors:  Lingling Huang; Chanisa Thonusin; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Eur J Nutr       Date:  2021-01-29       Impact factor: 5.614

Review 3.  The effects of probiotic and synbiotic supplementation on inflammation, oxidative stress, and circulating adiponectin and leptin concentration in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.

Authors:  Kaveh Naseri; Saeede Saadati; Farahnaz Ghaemi; Damoon Ashtary-Larky; Omid Asbaghi; Amir Sadeghi; Reza Afrisham; Barbora de Courten
Journal:  Eur J Nutr       Date:  2022-10-14       Impact factor: 4.865

4.  Is There an Epidemic of Research Fraud in Natural Medicine?

Authors:  Alan R Gaby
Journal:  Integr Med (Encinitas)       Date:  2022-05

5.  The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Alireza Farrokhian; Fariba Raygan; Ali Soltani; Maryam Tajabadi-Ebrahimi; Mehran Sharifi Esfahani; Ali Akbar Karami; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

6.  The Effects of Synbiotic Supplementation on Glucose Metabolism and Lipid Profiles in Patients with Diabetes: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Reza Tabrizi; Mahmood Moosazadeh; Kamran B Lankarani; Maryam Akbari; Seyed Taghi Heydari; Fariba Kolahdooz; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

7.  Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being.

Authors:  Karaponi Am Okesene-Gafa; Abigail E Moore; Vanessa Jordan; Lesley McCowan; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2020-06-24

8.  Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Hana Koutnikova; Bernd Genser; Milena Monteiro-Sepulveda; Jean-Michel Faurie; Salwa Rizkalla; Jürgen Schrezenmeir; Karine Clément
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

9.  The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.

Authors:  Yanmin Chen; Mengkai Du; Jianyun Xu; Danqing Chen
Journal:  Lipids Health Dis       Date:  2017-12-14       Impact factor: 3.876

10.  The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Khadijeh Nasri; Mehri Jamilian; Elham Rahmani; Fereshteh Bahmani; Maryam Tajabadi-Ebrahimi; Zatollah Asemi
Journal:  BMC Endocr Disord       Date:  2018-04-12       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.